- Condition: Morbid Obesity
Interventions: Drug: Ephedrine sulfate with caffeine; Drug: cellulose
Sponsors: Oregon Weight Loss Surgery, LLC; Oregon Weight Loss Surgery, LLC
Not yet recruiting - verified May 2012 - Conditions: Dietary Supplements; Heart Rate/Drug Effects; Lactic Acid/Metabolism; Physical Education and Training/Methods; Wheelchairs
Interventions: Dietary Supplement: Caffeine; Dietary Supplement: Sodium Citrate; Dietary Supplement: Mannitol; Dietary Supplement: Sodium Chloride
Sponsors: Swiss Paraplegic Centre Nottwil; Swiss Paraplegic Centre Nottwil
Recruiting - verified May 2012 - Condition: Advanced Solid Tumors, Excluding Breast Cancer
Interventions: Drug: caffeine; Drug: diclofenac; Drug: omeprazole; Drug: midazolam; Drug: TKI258
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Obesity
Interventions: Dietary Supplement: placebo; Dietary Supplement: green tea (757 mg/capsule [84.5 mg EGCG + 2.1 mg caffeine ]
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Not yet recruiting - verified March 2012 - Conditions: Diabetes Mellitus; Depression
Interventions: Behavioral: Healthy Outcomes through Patient Empowerment (HOPE); Behavioral: Enhanced Usual Care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified April 2012 - Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCondition: Hepatitis C, Chronic
Interventions: Drug: tenofovir; Drug: ribavirin; Drug: ribavirin; Drug: ribavirin; Drug: caffeine; Drug: caffeine; Drug: midazolam; Drug: midazolam; Drug: tolbutamide; Drug: tolbutamide; Drug: pegylated inteferon; Drug: pegylated interferon; Drug: BI 201335; Drug: BI 201335; Drug: BI 201335; Drug: BI 207127; Drug: BI 207127; Drug: BI 207127
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Nocturia
Intervention: Behavioral: SyBeMeP (Systemized Behavioural Modification education Program)
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Ferring Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012 - Conditions: Placebo Effect; Drug Half Life; Pharmacokinetics
Interventions: Drug: Caffeine, paracetamol, cephalexin, or ibuprofen; Drug: Placebo (caffeine, paracetamol, cephalexin, or ibuprofen)
Sponsors: King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center
Not yet recruiting - verified December 2011 - Condition: Critical Limb Ischemia
Interventions: Biological: Ixmyelocel-T; Other: Vehicle Control
Sponsors: Aastrom Biosciences; Aastrom Biosciences
Recruiting - verified May 2012 - Conditions: Bronchiolitis; Apnea; Caffeine
Interventions: Drug: Caffeine citrate; Drug: Normal saline
Sponsors: Hamad Medical Corporation; Hamad Medical Corporation
Recruiting - verified November 2011 - Condition: Pain
Interventions: Drug: IBUPROFEN + CAFFEINE; Drug: IBUPROFEN
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Not yet recruiting - verified February 2012 - Condition: Cardiovascular Risk
Intervention: Dietary Supplement: Energy Drink, Taurine, Caffeine
Sponsors: University of Hohenheim; University of Hohenheim
Recruiting - verified August 2011 - Condition: Low Back Pain
Interventions: Drug: Tandrilax; Drug: Dolamin Flex
Sponsors: Farmoquimica S.A.; Farmoquimica S.A.; Pharmagenix Projetos em Medicina Farmacêutica Ltda.
Not yet recruiting - verified March 2012 - Condition: Apnea of Prematurity
Intervention: Drug: NPC-11 for intravenous or oral administration.
Sponsors: Nobelpharma; Nobelpharma
Recruiting - verified April 2012 - Condition: Tensional-type Headache
Interventions: Drug: MIGRANE; Drug: PARCEL
Sponsors: EMS; EMS
Not yet recruiting - verified August 2011 - Conditions: Non Small-cell Lung Cancer; Renal-cell Cancer; Gastrointestinal Stroma Tumor
Interventions: Drug: Sunitinib; Drug: Erlotinib; Drug: Midazolam; Drug: Caffeine
Sponsors: Cantonal Hospital of St. Gallen; Cantonal Hospital of St. Gallen; University of Basel
Not yet recruiting - verified July 2011 - Conditions: Cognitive Function; Mood; Cerebral Haemodynamics; Caffeine Withdrawal
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Caffeine and Placebo; Dietary Supplement: Placebo and Caffeine; Dietary Supplement: Caffeine
Sponsors: Northumbria University; Northumbria University
Recruiting - verified June 2011 - Condition: Congestive Heart Failure
Interventions: Device: HeartWare® VAS; Other: Optimal Medical Management
Sponsors: University of Michigan; University of Michigan; HeartWare, Inc.; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified January 2012 - Condition: Overactive Bladder
Interventions: Device: (VERV™ System); Device: Sham version of (VERV™ System)
Sponsors: Ethicon Endo-Surgery; Ethicon Endo-Surgery; Novella Clinical, Inc.; Data & Inference, Inc.
Recruiting - verified April 2012 - Conditions: Obstructive Sleep Apnea; Enlargement of Tonsil or Adenoid
Interventions: Drug: Caffeine and sodium Benzoate 10 mg/kg IV; Drug: Caffeine and Sodium Benzoate 20 mg/kg IV; Drug: 0.9 NS Saline
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Memorial Hermann Hospital
Recruiting - verified March 2012 - Condition: Alcohol or Other Drugs Effects
Interventions: Drug: Alcohol + Caffeine Beverage; Drug: Alcohol + Caffeine-placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2011 - Condition: Sleepiness
Interventions: Other: Real driving situation; Other: Driving simulator
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux; ERANET; INSERM ERI27 Mobilités Cognition et Temporalité; Centre du Sommeil et de la Vigilance - Hôpital Hôtel – Dieu; IMF, CNRS UMR-5231
Recruiting - verified October 2011 - Condition: Apnea of Prematurity
Interventions: Drug: Caffeine citrate injection; Drug: placebo
Sponsors: McMaster University; McMaster University; Canadian Institutes of Health Research (CIHR); National Institutes of Health (NIH)
Recruiting - verified August 2011 - Condition: Heart Failure
Intervention: Device: Medtronic CareLink® Network
Sponsors: Medtronic Bakken Research Center; Medtronic Bakken Research Center
Recruiting - verified February 2012 - Conditions: Apnea of Prematurity; Intraventricular Hemorrhage; White Matter Injury
Intervention: Drug: Caffeine citrate
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive BladderCondition: Overactive Bladder
Interventions: Behavioral: Dietary Caffeine reduction; Drug: Anticholinergic medication
Sponsors: IWK Health Centre; IWK Health Centre
Recruiting - verified July 2011 - Conditions: Acute Myocardial Infarction (AMI); Coronary Occlusion; Acute Coronary Syndrome
Intervention: Device: AngelMed Guardian System
Sponsors: Angel Medical Systems; Angel Medical Systems; Symbios Clinical
Recruiting - verified April 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012
 |
Join Clinical trials for Caffeine |
